Legal Representation
Attorney
DAVID A. JACKSON
USPTO Deadlines
Application History
15 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Aug 2, 2019 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Aug 2, 2019 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Jan 4, 2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Jan 4, 2019 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Jan 4, 2019 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Dec 17, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Dec 17, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 17, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 18, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 18, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jun 18, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 14, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 10, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Mar 9, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 6, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific research, pharmaceutical research, medical research; technical and scientific consultation and product development services, including for others, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, and rare diseases, and to pharmaceuticals; providing on line information for medical research purposes, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases, treatments for immune mediated diseases, inflammatory diseases, and rare diseases, and pharmaceuticals
Additional Information
Design Mark
The mark consists of DNA double helix, with the left-hand helix in black and the right-hand helix in orange.
Color Claim
The color(s) black and orange is/are claimed as a feature of the mark.
Classification
International Classes
042